Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis

  15 January 2021

The proportion of patients infected with SARS-CoV-2 that are prescribed antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance. Our objective was to estimate the prevalence and associated factors of antibiotic use in patients with confirmed COVID-19

Three-quarters of patients with COVID-19 receive antibiotics, prescribing is significantly higher than the estimated prevalence of bacterial co-infection. Unnecessary antibiotic use is likely high in patients with COVID-19.

Author(s): Bradley J. Langford, PharmD Miranda So, PharmD Sumit Raybardhan, BScPhm MPH Valerie Leung, BScPhm MBA Jean-Paul R. Soucy, MSc Duncan Westwood, BA Nick Daneman, MD, MSc Derek R. MacFadden, MD, ScD
Healthy Patients  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre


JSS University


Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!